Sound Blade Medical develops innovative handheld ultrasound-guided histotripsy technology for non-invasive tissue ablation.

XyloCor Therapeutics develops gene therapies for cardiovascular diseases, focusing on treatments for refractory angina and coronary artery bypass graft surgery.

Axonis Therapeutics is a biotechnology company developing novel neuromedicines targeting neurological disorders like epilepsy and pain.

Alpha-9 Oncology Inc. develops targeted radiopharmaceuticals to improve cancer treatment.

SpectraWAVE, Inc. develops advanced medical imaging systems to improve coronary stenting procedures and enhance clinical decision-making in the treatment of coronary artery disease.

HistoSonics is a medical device company that develops non-invasive histotripsy platforms, including the Edison® Histotripsy System, to mechanically destroy and liquefy targeted liver tumors using focused ultrasound.

Specific Biologics is a biotechnology company focused on developing therapeutics for genetic diseases using its proprietary Dualase® platform gene editors.

Deka Biosciences is a biotech company that aims to improve immunotherapy treatments by combining biology with precision medicine, specifically through their investigational new drug, DK210 (EGFR), which has dissociated IL-2 potency from toxicity.